Table of Contents
<< Previous Issue | Jan 2005 (Vol: 2005, Issue: 55) | Next Issue >> |
- Section: Business Commentaries
-
Seeking the 'Delta'
- Section: Company Profile
-
Recordati SpA
- Section: Deal Trackers
-
Tarceva (erlotinib)
- Section: Distribution & Marketing
-
Genzyme Reacquires Arthritis Pain Treatment from Wyeth
- Section: Features
-
Bayer: Seeking Reformulation
-
Medarex's Second Recent US$0.5 B Deal
-
Latin America: A Changing Landscape
-
Therapy Focus: Inflammatory Bowel Disease
- Section: General
-
Forest Bolsters its CNS Portfolio
- Section: Licensing
-
Serono and Nautilus Sign Hormone Agreement
- Section: Mergers & Acquisitions
-
Agis Puts an End to Merger Rumours
-
Dainippon and Sumitomo Follow in the Footsteps of Yamanouchi and Fujisawa
- Section: Research & Development
-
MedImmune Seeks Portfolio Expansion with Medarex Collaboration
-
AstraZeneca Takes Stake in Cambridge Antibody Technology alongside Antibody Discovery Alliance